Critical Path Ventures
Accelerating the first steps of deeptech researcher-entrepreneurs
ABOUT
Since 2022, Critical Path Ventures has been investing in innovative scientific research projects, financially supporting startups created by researchers-entrepreneurs from the seed phase.
Often co-investing, Critical Path Ventures selects an average of six projects per year, mainly in the physics, medicine, biotechnology and robotics sectors, promoting the development of industry and maintaining employment in France.
THE STRENGTHS OF CRITICAL PATH VENTURES
EARLY STAGE INVESTMENT
We engage with deeptech startups from their earliest stages. We provide substantial financial resources to secure the critical early stages of development, while intervening earlier than a traditional VC. Our approach fills this early-stage funding gap, allowing founders to focus on their technology and market without compromise.
SCIENTIFIC SUPPORT
Our management team is comprised of internationally renowned scientists with extensive entrepreneurial experience. This combined expertise allows us to identify high-potential technologies at a very early stage. Startups thus benefit from strategic and operational support, particularly during critical R&D phases, to accelerate their trajectory while reducing technological risks.
THE CRITICAL NETWORK
We foster direct synergies between the startups in our portfolio, integrating them into an ecosystem of sharing and trust. They thus benefit from the experiences, resources, and contacts of the other companies we support, creating a collective dynamic that strengthens their development and their ability to meet technological and industrial challenges.
